Related Experiment Video
Updated: Jul 26, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Clinical use of a test for determination of coagulation factors II, X and VII]
Abstract:
A new clotting test, the Hepato-Quick, indicated in the study of liver insufficiency was used in 102 patients comprising 22 cases of acute hepatitis, 15 of chronic hepatitis, 21 of cirrhosis of the liver, 11 with liver conditions of various nature, 23 cases with a number of diseases without liver impairment and 10 normal subjects. Quick's test was carried out at the same time in all subjects. Results show that the Hepato-Quick test is more sensitive than Quick's test for identifying liver impairment. The greater sensitivity is statistically significant. The test presents excellent standardization and can be carried out on automatic equipment.
More Related Videos
04:56Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Venous Thrombosis III: Interprofessional Care